Daily clinical lab news - Labmedica.com

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars Advertise with Us

INTEGRA BIOSCIENCES AG

RANDOX LABORATORIES

Sekisui Diagnostics

Download Mobile App

Trending Articles

Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)

Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

40-Gene Test Validated for High-Risk Squamous Cell Carcinoma

AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence

Events

more events

27 Sep 2026 - 30 Sep 2026

IATDMCT 2026 – 24th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology

28 Sep 2026 - 02 Oct 2026

DKLM 2026 – Annual Congress of the German Society for Clinical Medicine& Laboratory Medicine (DGKL)

28 Sep 2026 - 02 Oct 2026

EASD 2026 – European Association for the Study of Diabetes

Partner Sites

HospiMedica

FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

New Sensor Could Bring Contactless Vital Sign Monitoring to Hospital Bedsides

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen’s Aptiva Antiphospholipid Syndrome Immunoglobulin A (IgA) Reagent has received U.S. FDA 510(k) clearance and CE Mark under IVDR.
Read more
23 Sep 2026

New Donor Genetic Marker May Help Predict Stem Cell Transplant Success

23 Sep 2026

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

23 Sep 2026

Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens

23 Sep 2026

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

23 Sep 2026

Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

23 Sep 2026

Visit expo >

Platinum Member

Automated Coagulation Analyzer

Hemolumi H6

Gold Member

Blood-Based Protein Biomarker Solution for Alzheimer's Disease

BG-DTi2000.

Gold Member

POCT RT-qPCR Analyzer

BG-X6

New

Gold Member

Platelet Function Analyzer

PL-12

In Other News

Image: GRAIL’s Galleri test uses machine learning to analyze cfDNA patterns for cancer signals and predict their likely location to guide further evaluation.

Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

New findings show that adding a MCED blood test to standard screening increased early cancer detection 6.5-fold with 99.6% specificity. Read more
23 Sep 2026 | Clinical Chem.

Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

A new blood-based tumor DNA test distinguishes malignant from benign nerve sheath tumors and supports earlier monitoring in neurofibromatosis. Read more
23 Sep 2026 | Molecular Diagnostics

Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

New data show infant gut microbiome maturation trajectories stratify risk of type 1 diabetes and early autoimmune activity. Read more
22 Sep 2026 | Microbiology

Image: cCMV screening is not universal in U.S. newborns, yet over 40% of children who develop related hearing loss initially pass newborn hearing screening, highlighting the need for broader approaches (Image Credit: iStock)

Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus

A system-wide newborn cCMV screening program using swab and urine tests boosts detection 2.5-fold and enables earlier care. Read more
22 Sep 2026 | Microbiology

FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

A direct-from-specimen urine ID/AST panel received FDA Breakthrough status to support same-day organism identification and susceptibility testing. Read more
22 Sep 2026 | Microbiology

Image: Volcano plot of overrepresented genes in H10544. (Zhichen Zhu et al., Antimicrobial Agents and Chemotherapy (2026). DOI: 10.1128/aac.00506-26)

Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

New findings map K. pneumoniae drug resistance, reveal trade-offs that restore last-line treatment sensitivity, and support targeted prevention. Read more
22 Sep 2026 | Microbiology

Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

New findings for Natera's Signatera molecular residual disease (MRD) test were presented at the IASLC 2026 World Conference. Read more
22 Sep 2026 | Molecular Diagnostics

Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Siemens Healthineers and Novo have partnered to advance MASLD and MASH care through earlier assessment and broader access to noninvasive testing. Read more
22 Sep 2026 | Industry

Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

A new blood test helps guide antiplatelet treatment after heart attack or stroke by flagging clotting or bleeding risk. Read more
22 Sep 2026 | Clinical Chem.

Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

A new multiomic blood test uses 5hmC, genomic, and glycan signals to noninvasively monitor therapy and subtype pancreatic cancer. Read more
22 Sep 2026 | Molecular Diagnostics

Image: The OhmX Platform uses electronic genome mapping to analyze ultra-long DNA molecules, combining electronic detection, nanofluidics, and computational biology in a compact system for high-resolution genome structure analysis. (Photo courtesy of Nabsys)

Electronic Genome Mapping Reveals Structural Abnormalities in Hematologic Malignancies

An electronic genome mapping system matches standard methods while detailing structural DNA changes in leukemias. Read more
22 Sep 2026 | Molecular Diagnostics

Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Multispectral imaging profiles blood vessel patterns in colorectal tumors and links vessel features to survival. Read more
21 Sep 2026 | Pathology

Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

A new multimodal AI test improves early and late distant recurrence prediction in HR+/HER2- breast cancer. Read more
21 Sep 2026 | Pathology

Channels

Clinical Chemistry

view channel

Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Image Credit: Diane E. MacDougall et al., FIND Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease, JACC: Advances (2026). DOI: 10.1016/j.jacadv.2026.103114

Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)

Lipoprotein(a) is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease, yet routine screening remains uncommon despite guideline recommendations, leaving many high-risk... Read more

Blood Biomarker May Help Monitor Early Response to Lecanemab in Alzheimer’s Disease

Alzheimer’s disease is a progressive neurodegenerative disorder marked by amyloid-beta and tau pathology and remains a leading cause of cognitive decline in older adults. Although lecanemab, an anti-amyloid... Read more

Molecular Diagnostics

view channel

Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

Lung cancer is commonly associated with tobacco exposure, yet diagnoses among people who have never smoked are increasing, and the contribution of inherited risk remains poorly understood.... Read more

Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

FDA Clears Compact Molecular COVID Test for Decentralized Care Settings

Decentralized healthcare settings such as urgent care clinics have historically struggled to deploy high-performance molecular testing. Barriers include high upfront costs, fixed testing capacity, large... Read more

Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers

Early detection of stage I solid cancers remains a significant unmet clinical need. Liquid biopsy approaches that can distinguish tumor-derived signals from background cell-free DNA are therefore drawing... Read more

Hematology

view channel

Image Credit: American Society of Hematology

Updated Ferritin Thresholds Improve Detection of Iron Deficiency

Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read more

New Automated Hemostasis Systems Become Available Across US Laboratories

Hemostasis testing supports critical decisions in surgery, anticoagulation management, and the evaluation of bleeding and thrombotic disorders, but laboratories continue to face rising volumes and complex... Read more

Image: Acute myeloid leukemia is an aggressive blood cancer in which relapse remains a major challenge, making MRD detection critical for risk assessment and treatment planning (Image Credit: Shutterstock)

Variation in AML Residual Disease Testing Prompts Push for Standardization

Acute myeloid leukemia (AML) is an aggressive blood cancer in which relapse after therapy remains a persistent challenge, making measurable residual disease (MRD) detection central to risk assessment and... Read more

Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed

Immune-mediated thrombosis following heparin therapy can be sudden and severe, creating urgent diagnostic challenges. In heparin-induced thrombocytopenia (HIT), antibodies against platelet factor 4 (PF4)... Read more

Immunology

view channel

Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Image Credit: Adobe Stock

New Cellular Map May Help Predict Crohn’s Disease Course in Children

Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more

Image Credit: Adobe Stock

Temporal Immune Profiling Reveals How Sepsis States Change Over Time

Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more

Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read more

Microbiology

view channel

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Image: Graphical Abstract (Zeyang Shen et al., Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease, Allergy, 2026. DOI: 10.1111/all.70449)

Infant Skin Microbiome Show Links to Later Eczema and Food Allergies

Eczema, or atopic dermatitis, and food allergies often begin in infancy and are among the earliest stages of the atopic march. Atopic dermatitis alone can affect up to 20% of children, yet objective indicators... Read more

Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures

Hospitals face persistent pressure to improve diagnostic accuracy while reducing unnecessary testing and costs. Misordered or overused assays can complicate infection metrics, trigger penalties, and strain... Read more

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Pathology

view channel

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

Standardized biomarker reporting and molecular profiling are central to pathology-driven cancer care, but evolving practices require laboratories to keep reporting templates current. These templates capture... Read more

Image: The workflow analyzes slides already generated during routine care, providing added prognostic information without requiring another tissue test (Image Credit: Shutterstock)

AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence

Predicting which patients with pancreatic cancer will recur after treatment and surgery remains challenging. Pathology evaluation typically measures residual tumor burden, but recent work found that tumor... Read more

Technology

view channel

Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read more

Industry

view channel

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more

Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent

Asia accounts for nearly two-thirds of lung cancer cases worldwide, with an estimated 1.6 million new diagnoses across the region each year. Against this substantial disease burden, a newly granted patent... Read more

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more

Image: Concentriq AP-Dx supports primary diagnosis from digital pathology slides and is FDA-cleared, Health Canada-licensed, and CE-marked under the EU IVDR. (Photo courtesy of Proscia)

Unilabs Expands Digital Pathology Across European Network with Proscia Platform

As precision medicine expands, digital pathology platforms must connect teams, sites, diagnostic data, and artificial intelligence to accelerate routine diagnosis. Sharing expertise across laboratory networks... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC

Copyright © 2000-2026 Globetech Media. All rights reserved.

MOBILE | FULL SITE